Literature DB >> 25714144

Searching the co-occurrence of pathogenic mutations for Leber's hereditary optic neuropathy and hearing loss in more than 26,000 whole mitochondrial genomes.

Haixin Yang1, Rui Liu2, Chuan-Chao Wang2.   

Abstract

The co-occurrence of pathogenic or candidate mutations for Leber's hereditary optic neuropathy (LHON) and hearing loss has long been suggested to be a rare incident. The "rare" is probably caused by inadequate database searches. In this study, we created and released a comprehensive database with detailed information of haplogroup, variants, coding sites, and potential pathogenic mutations for more than 26,000 whole mitochondrial genomes. We found the co-occurrence in more than 200 individuals including not only LHON or hearing loss patients but also individuals sampled from general populations with various haplogroup backgrounds. The results highlighted the significant importance of adequate database searching in the genetic analysis of mitochondrial disorders.

Entities:  

Keywords:  Database; LHON; hearing loss; mitochondrial genome; pathogenic mutation

Mesh:

Year:  2015        PMID: 25714144     DOI: 10.3109/19401736.2015.1018239

Source DB:  PubMed          Journal:  Mitochondrial DNA A DNA Mapp Seq Anal        ISSN: 2470-1394            Impact factor:   1.514


  2 in total

1.  Iterative Sequencing and Variant Screening (ISVS) as a novel pathogenic mutations search strategy - application for TMPRSS3 mutations screen.

Authors:  Urszula Lechowicz; Tomasz Gambin; Agnieszka Pollak; Anna Podgorska; Piotr Stawinski; Andre Franke; Britt-Sabina Petersen; Malgorzata Firczuk; Monika Oldak; Henryk Skarzynski; Rafal Ploski
Journal:  Sci Rep       Date:  2017-05-31       Impact factor: 4.379

2.  Decreased Volume of Lateral and Medial Geniculate Nuclei in Patients with LHON Disease-7 Tesla MRI Study.

Authors:  Kamil Jonak; Paweł Krukow; Katarzyna E Jonak; Elżbieta Radzikowska; Jacek Baj; Anna Niedziałek; Anna Pankowska; Mark Symms; Andrzej Stępniewski; Arkadiusz Podkowiński; Ida Osuchowska; Cezary Grochowski
Journal:  J Clin Med       Date:  2020-09-10       Impact factor: 4.241

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.